Abstract
The effects of the oral beta agonist pirbuterol on pulmonary haemodynamics and gas exchange were studied in nine patients with severe irreversible airflow obstruction and moderate arterial hypoxaemia. After administration of 15 mg pirbuterol pulmonary vascular resistance fell by 19% but cardiac output rose by 24%, so that pulmonary arterial pressure showed no significant change. Systemic arterial oxygen pressure fell by 7%, limiting the rise in oxygen delivery to 21%. All changes were significant at the 2% level. These results show that pirbuterol dilates the pulmonary bed at the cost of a slight worsening of gas exchange, which is compensated by an independent rise in blood flow.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Awan N. A., Needham K. E., Evenson M. K., Mason D. T. Comparison of hemodynamic actions of pirbuterol and dobutamine on cardiac function in severe congestive heart failure. Am J Cardiol. 1981 Mar;47(3):665–669. doi: 10.1016/0002-9149(81)90552-x. [DOI] [PubMed] [Google Scholar]
- Bergofsky E. H. Tissue oxygen delivery and cor pulmonale in chronic obstructive pulmonary disease. N Engl J Med. 1983 May 5;308(18):1092–1094. doi: 10.1056/NEJM198305053081809. [DOI] [PubMed] [Google Scholar]
- Canepa-Anson R., Dawson J. R., Kuan P., Warnes C. A., Poole-Wilson P. A., Reuben S. R., Sutton G. C. Single-dose and dose-response studies with oral pirbuterol, a new beta agonist in chronic heart failure. Am Heart J. 1981 Sep;102(3 Pt 2):578–583. doi: 10.1016/0002-8703(81)90747-x. [DOI] [PubMed] [Google Scholar]
- Colucci W. S., Alexander R. W., Mudge G. H., Rude R. E., Holman B. L., Wynne J., Grossman W., Braunwald E. Acute and chronic effects of pirbuterol on left ventricular ejection fraction and clinical status in severe congestive heart failure. Am Heart J. 1981 Sep;102(3 Pt 2):564–568. doi: 10.1016/0002-8703(81)90745-6. [DOI] [PubMed] [Google Scholar]
- Diener C. F., Burrows B. Further observations on the course and prognosis of chronic obstructive lung disease. Am Rev Respir Dis. 1975 Jun;111(6):719–724. doi: 10.1164/arrd.1975.111.6.719. [DOI] [PubMed] [Google Scholar]
- Gold F. L., Horwitz L. D. Hemodynamic effects of pirbuterol in conscious dogs. Am Heart J. 1981 Sep;102(3 Pt 2):591–596. doi: 10.1016/0002-8703(81)90749-3. [DOI] [PubMed] [Google Scholar]
- Honey M., Cotter L., Davies N., Denison D. Clinical and haemodynamic effects of diazoxide in primary pulmonary hypertension. Thorax. 1980 Apr;35(4):269–276. doi: 10.1136/thx.35.4.269. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ude A. C., Howard P. Controlled oxygen therapy and pulmonary heart failure. Thorax. 1971 Sep;26(5):572–578. doi: 10.1136/thx.26.5.572. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Weitzenblum E., Hirth C., Ducolone A., Mirhom R., Rasaholinjanahary J., Ehrhart M. Prognostic value of pulmonary artery pressure in chronic obstructive pulmonary disease. Thorax. 1981 Oct;36(10):752–758. doi: 10.1136/thx.36.10.752. [DOI] [PMC free article] [PubMed] [Google Scholar]